KAIVAL BRANDS INNOVATIONS GR (KAVL)

US4831044023 - Common Stock

0.781  -0.08 (-9.3%)

After market: 0.83 +0.05 (+6.27%)

Fundamental Rating

1

Overall KAVL gets a fundamental rating of 1 out of 10. We evaluated KAVL against 15 industry peers in the Distributors industry. KAVL may be in some trouble as it scores bad on both profitability and health. KAVL has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year KAVL has reported negative net income.
KAVL had a negative operating cash flow in the past year.
In the past 5 years KAVL reported 4 times negative net income.
In the past 5 years KAVL reported 4 times negative operating cash flow.

1.2 Ratios

The Return On Assets of KAVL (-45.44%) is worse than 92.86% of its industry peers.
KAVL's Return On Equity of -58.89% is on the low side compared to the rest of the industry. KAVL is outperformed by 85.71% of its industry peers.
Industry RankSector Rank
ROA -45.44%
ROE -58.89%
ROIC N/A
ROA(3y)-67.82%
ROA(5y)N/A
ROE(3y)-94.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

KAVL's Gross Margin of 28.94% is in line compared to the rest of the industry. KAVL outperforms 57.14% of its industry peers.
In the last couple of years the Gross Margin of KAVL has grown nicely.
The Profit Margin and Operating Margin are not available for KAVL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.95%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

KAVL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KAVL has been increased compared to 1 year ago.
The number of shares outstanding for KAVL has been increased compared to 5 years ago.
The debt/assets ratio for KAVL is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -2.46, we must say that KAVL is in the distress zone and has some risk of bankruptcy.
KAVL has a Altman-Z score of -2.46. This is amonst the worse of the industry: KAVL underperforms 85.71% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that KAVL is not too dependend on debt financing.
KAVL has a Debt to Equity ratio of 0.03. This is in the better half of the industry: KAVL outperforms 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -2.46
ROIC/WACCN/A
WACC12.45%

2.3 Liquidity

KAVL has a Current Ratio of 1.76. This is a normal value and indicates that KAVL is financially healthy and should not expect problems in meeting its short term obligations.
KAVL has a Current ratio (1.76) which is comparable to the rest of the industry.
KAVL has a Quick Ratio of 1.70. This is a normal value and indicates that KAVL is financially healthy and should not expect problems in meeting its short term obligations.
KAVL has a better Quick ratio (1.70) than 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.7

0

3. Growth

3.1 Past

KAVL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.68%, which is quite impressive.
KAVL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.74%.
KAVL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -41.18% yearly.
EPS 1Y (TTM)39.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)-16.74%
Revenue growth 3Y-41.18%
Revenue growth 5YN/A
Sales Q2Q%-80.08%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y200%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year101.67%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

KAVL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 19.14 indicates a rather expensive valuation of KAVL.
KAVL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. KAVL is cheaper than 64.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of KAVL to the average of the S&P500 Index (22.83), we can say KAVL is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 19.14

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

KAVL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for KAVL!.
Industry RankSector Rank
Dividend Yield N/A

KAIVAL BRANDS INNOVATIONS GR

NASDAQ:KAVL (12/20/2024, 8:21:05 PM)

After market: 0.83 +0.05 (+6.27%)

0.781

-0.08 (-9.3%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)09-17 2024-09-17
Earnings (Next)N/A N/A
Inst Owners0.11%
Inst Owner Change798.6%
Ins Owners0.18%
Ins Owner Change0%
Market Cap5.30M
Analysts82.86
Price Target32.13 (4013.96%)
Short Float %1.04%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-93.91%
Min Revenue beat(2)-97.22%
Max Revenue beat(2)-90.59%
Revenue beat(4)0
Avg Revenue beat(4)-88.61%
Min Revenue beat(4)-97.22%
Max Revenue beat(4)-80.79%
Revenue beat(8)0
Avg Revenue beat(8)-70.36%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.14
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 1.99
EV/EBITDA N/A
EPS(TTM)-2.59
EYN/A
EPS(NY)0.04
Fwd EY5.22%
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS1.49
BVpS2
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.44%
ROE -58.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.94%
FCFM N/A
ROA(3y)-67.82%
ROA(5y)N/A
ROE(3y)-94.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.95%
GM growth 5YN/A
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.7
Altman-Z -2.46
F-Score6
WACC12.45%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next Y200%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.74%
Revenue growth 3Y-41.18%
Revenue growth 5YN/A
Sales Q2Q%-80.08%
Revenue Next Year101.67%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y99.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.97%
OCF growth 3YN/A
OCF growth 5YN/A